10.48
10.48 (0%)
As of Feb 14, 2025
Cormedix Inc. [CRMD]
Source:
Company Overview
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions.
| Country | United States |
| Headquarters | berkeley heights, new jersey |
| Phone Number | (908) 517-9500 |
| Industry | manufacturing |
| CEO | Joseph Todisco |
| Website | www.cormedix.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $11.5 |
| Operating Profit | $-3.3 |
| Net Income | $-2.8 |
| Net Cash | $-8.4 |
Profit Ratios
| Gross Margin | $10.8 |
| Operating Margin | -28.7 |
| Profit as % of Revenues | -387.8% |
| Profit as % of Assets | -6.2% |
| Profit as % of Stockholder Equity | -4.7% |
Management Effectiveness
| Return on Equity | -4.7% |
| Return on Assets | -3.6% |
| Turnover Ratio | 25.7% |
| EBITA | $-3.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $77.6 |
| Total Liabilities | $18.9 |
| Operating Cash Flow | $-45 |
| Investing Cash Flow | $21.5 |
| Financing Cash Flow | $15 |
